Login Register Cart 0
Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Simultaneous Determination of Saponins and Lignans in Rat Plasma by UPLC- MS/MS and its Application to a Pharmacokinetic Study of Shenqi Jiangtang Granule

Author(s): Hui Zhang*, Ruoyu Chen, Cong Xu, Ya Zhang, Qinghua Tian, Baoling Wang, Guimin Zhang, Yongxia Guan and Jizhong Yan*

Volume 22, Issue 3, 2021

Published on: 03 February, 2021

Page: [224 - 231] Pages: 8

DOI: 10.2174/1389200222666210203182232

Price: $65

Abstract

Background: Shenqi Jiangtang Granule (SJG), a classical prescription of traditional Chinese medicine, is widely used to treat diabetes and its complications. Although, the clinical efficacy of SJG, is sufficient, the pharmacokinetic behavior of various substances in the plasma of SJG is unknown.

Objective: The aim of this study was to investigate the plasma pharmacokinetics during absorption of SJG after oral administration in rats.

Methods: A rapid and accurate ultra-high performance liquid chromatography/tandem mass spectrometry (UPLC- MS/MS) method was developed for the simultaneous determination of eight analytes in SJG, including gomisin D, schisandrin A, schisandrin B, schizandrol A, schizandrol B, ginsenoside Rd, ginsenoside Re and notoginsenoside Ft1. The analysis was carried out on a BEH C18 column (2.1 mm × 50 mm, 1.7 μm) with gradient elution at a flow rate of 0.2 mL/min in a mobile phase consisting of 0.1% formic acid water and acetonitrile. In addition, lignans and saponins were detected in positive ion mode and negative ion mode, respectively.

Results: Eight analytes in SJG, including gomisin D, schisandrin A, schisandrin B, schizandrol A, schizandrol B, ginsenoside Rd, ginsenoside Re and notoginsenoside Ft1, showed good linearity (R2 in the range of 0.9955 ~ 0.9999). The lower limit of quantification (LLOQ) was 5, 0.8, 0.8, 8, 0.8, 5, 0.6 and 10 ng/mL. The accuracy and precision of all analytes were at ±15%. Matrix effect and average extraction recovery were > 85%. All analytes performed well under four storage conditions.

Conclusion: The results showed that in vivo absorption and exposure of gomisin D and ginsenoside Rd were better than other analytes, while schizandrol B and notoginsenoside Ft1 were poorly absorbed. This approach could be applied to study the pharmacokinetic characteristics of various analytes in plasma after oral administration of SJG in rats.

Keywords: Traditional Chinese medicine, shenqi jiangtang granule, UPLC-MS/MS, pharmacokinetic study, quantitative detection, diabetes mellitus.

« Previous Next »
Graphical Abstract

[1]
Domingueti, C.P.; Dusse, L.M.; Carvalho, Md.; de Sousa, L.P.; Gomes, K.B.; Fernandes, A.P. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J. Diabetes Complications, 2016, 30(4), 738-745.
[http://dx.doi.org/10.1016/j.jdiacomp.2015.12.018] [PMID: 26781070]
[2]
Wang, C.; Yu, J.; Zhang, R.; Wang, W.; Shi, Z.; Liu, Y.; Song, G.; Wang, H.; Han, N.; Huang, L.; An, Y.; Tian, S.; Chen, Z. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus. J. Proteomics, 2020, 223, 103823.
[http://dx.doi.org/10.1016/j.jprot.2020.103823] [PMID: 32428569]
[3]
Udler, M.S. Type 2 diabetes: multiple genes, multiple diseases. Curr. Diab. Rep., 2019, 19(8), 55.
[http://dx.doi.org/10.1007/s11892-019-1169-7] [PMID: 31292748]
[4]
Chauhan, D.S.; Gupta, P.; Pottoo, F.H.; Amir, M. Secondary metabolites in the treatment of diabetes mellitus: a paradigm shift. Curr. Drug Metab., 2020, 21(7), 493-511.
[http://dx.doi.org/10.2174/1389200221666200514081947] [PMID: 32407267]
[5]
Liu, S.; Zhang, R.; Shang, X.; Li, W. Analysis for warning factors of type 2 diabetes mellitus complications with Markov blanket based on a Bayesian network model. Comput. Methods Programs Biomed., 2020, 188, 105302.
[http://dx.doi.org/10.1016/j.cmpb.2019.105302] [PMID: 31923820]
[6]
Zhang, L.; Chen, Q.; Li, L.; Kwong, J.S.W.; Jia, P.; Zhao, P.; Wang, W.; Zhou, X.; Zhang, M.; Sun, X. Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis. Sci. Rep., 2016, 6, 32649.
[http://dx.doi.org/10.1038/srep32649] [PMID: 27596383]
[7]
Fu, J.; Liu, J.; Xu, Y.; Yang, N.; Yang, W.; Wang, G. Comparison of therapeutic effects of acarbose and metformin under different β-cell function status in Chinese patients with type 2 diabetes. Endocr. J., 2019, 66(5), 443-450.
[http://dx.doi.org/10.1507/endocrj.EJ18-0466] [PMID: 30944269]
[8]
Hu, R.F.; Sun, X.B. Design of new traditional Chinese medicine herbal formulae for treatment of type 2 diabetes mellitus based on network pharmacology. Chin. J. Nat. Med., 2017, 15(6), 436-441.
[http://dx.doi.org/10.1016/S1875-5364(17)30065-1] [PMID: 28629533]
[9]
Wang, J.; Ma, Q.; Li, Y.; Li, P.; Wang, M.; Wang, T.; Wang, C.; Wang, T.; Zhao, B. Research progress on traditional Chinese medicine syndromes of diabetes mellitus. Biomed. Pharmacother., 2020, 121, 109565.
[http://dx.doi.org/10.1016/j.biopha.2019.109565] [PMID: 31704615]
[10]
Bai, L.; Li, X.; He, L.; Zheng, Y.; Lu, H.; Li, J.; Zhong, L.; Tong, R.; Jiang, Z.; Shi, J.; Li, J. Antidiabetic potential of flavonoids from traditional chinese medicine: a review. Am. J. Chin. Med., 2019, 47(5), 933-957.
[http://dx.doi.org/10.1142/S0192415X19500496] [PMID: 31248265]
[11]
Tsai, Y.Y.; Chen, K.J.; Yang, Y.H.; Lin, Y.H. Use of traditional Chinese medicine may delay the need for insulin treatment in patients with type 2 diabetes: a population-based cohort study. J. Altern. Complement. Med., 2020, 26(7), 628-635.
[http://dx.doi.org/10.1089/acm.2019.0375] [PMID: 32543210]
[12]
Li, R.L.; Dong, T.W.; Wei, J.G.; Gao, F.; Li, M.; Bai, Y.; Wei, P.F.; Xi, M.M. Meta-analysis of the therapeutic effect of Shenqi Jiangtang granule on type 2 diabetes mellitus. Evid-Based Compl. Alt, 2020, 2020, 5754823.
[13]
Zhang, J.; Li, B.B.; Huang, M.Y.; Tan, L.P.; Xiao, X.; Zhang, G.M.; Guo, J. Mechanism of Shenqi Jiangtang granules in treatment of type 2 diabetes based on network pharmacology. Chin. Tradit. Herbal Drugs, 2020, 51(19), 4873-4883.
[14]
Zhang, Q.; Xiao, X.; Zheng, J.; Li, M.; Yu, M.; Ping, F.; Wang, T.; Wang, X. Shenqi Jiangtang granule ameliorates kidney function by inhibiting apoptosis in a diabetic rat model. Evid. Based Complement. Alternat. Med., 2019, 2019, 3240618.
[http://dx.doi.org/10.1155/2019/3240618] [PMID: 31827549]
[15]
Lu, J.H. Clinical analysis of Shenqi Jiangtang granules combined with metformin hydrochloride in treating type 2 diabetes mellius. China Pharm, 2017, 26(24), 50-52.
[16]
She, W.J.; Liu, J.Z.; Gong, H. Effects of Shenqi Jiangtang granules in the treatment of type 2 diabetic patients. World J. Tradit. Chin. Med, 2019, 14, 3294-3297.
[17]
Wang, H.Y.; Liu, T.H. A meta analysis of Shenqi Jiangtang granule treatment on diabetic nephropathy. World Sci. Tech, 2015, 17(12), 2608-2613.
[18]
Zhang, H.; Zhang, X.; Jiang, H.; Xu, C.; Tong, S.; Yan, J. Screening and identification of α-glucosidase inhibitors from Shenqi Jiangtang granule by ultrafiltration liquid chromatography and mass spectrometry. J. Sep. Sci., 2018, 41(3), 797-805.
[http://dx.doi.org/10.1002/jssc.201700835] [PMID: 29152897]
[19]
Zhang, H.; Zhang, X.J.; Jang, H.J.; Yan, J.Z. Analysis of chemical constituents in Shenqi Jiangtang granules by UPLC-Q-TOF MS/MS. Zhongchengyao, 2017, 39(10), 2101-2108.
[20]
Zhang, H.; Xu, C.; Tian, Q.; Zhang, Y.; Zhang, G.; Guan, Y.; Tong, S.; Yan, J. Screening and characterization of aldose reductase inhibitors from traditional Chinese medicine based on ultrafiltration-liquid chromatography mass spectrometry and in silico molecular docking. J. Ethnopharmacol., 2021, 264(264), 113282.
[http://dx.doi.org/10.1016/j.jep.2020.113282] [PMID: 32890716]
[21]
Liu, L.; Huang, J.; Hu, X.; Li, K.; Sun, C. Simultaneous determination of ginsenoside (G-Re, G-Rg1, G-Rg2, G-F1, G-Rh1) and protopanaxatriol in human plasma and urine by LC-MS/MS and its application in a pharmacokinetics study of G-Re in volunteers. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2011, 879(22), 2011-2017.
[http://dx.doi.org/10.1016/j.jchromb.2011.05.018] [PMID: 21704572]
[22]
Liu, H.; Yang, J.; Du, F.; Gao, X.; Ma, X.; Huang, Y.; Xu, F.; Niu, W.; Wang, F.; Mao, Y.; Sun, Y.; Lu, T.; Liu, C.; Zhang, B.; Li, C. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab. Dispos., 2009, 37(12), 2290-2298.
[http://dx.doi.org/10.1124/dmd.109.029819] [PMID: 19786509]
[23]
Song, W.; Zheng, W.; Zhang, J.; Zhang, T.; Liu, S.C.; Yu, L.Y.; Ma, B.P. Metabolism of saponins from traditional Chinese medicines: a review. Yao Xue Xue Bao, 2018, 53(10), 1609-1619.

Rights & Permissions Print Cite
Article Metrics
21
1
© 2024 Bentham Science Publishers | Privacy Policy